Brady James Aloysius — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Brady James Aloysius has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $71K.

Profile

Brady James Aloysius
RoleDirector
Notability30/100

Board memberships

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-05XERSXeris Biopharma Holdings, Inc.A — Grant or award24.2K$0.00
2026-04-01XERSXeris Biopharma Holdings, Inc.S — Open-market sale [10b5-1]10.8K$5.54$60K
2025-10-07VRNAVerona Pharma plcD — Derivative transaction72.0K—
2025-10-07VRNAVerona Pharma plcM — Option exercise72.0K—
2025-10-07VRNAVerona Pharma plcD — Derivative transaction23.2K—
2025-08-01VRNAVerona Pharma plcS — Open-market sale824$13.14$11K
2025-08-01VRNAVerona Pharma plcM — Option exercise24.0K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Brady James Aloysius?

Brady James Aloysius is a corporate insider — currently tracked as Director of Xeris Biopharma Holdings, Inc. (XERS). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Brady James Aloysius submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Brady James Aloysius been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 2 open-market sales ($71K) across all tracked filings.

Where can I see all of Brady James Aloysius's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Brady James Aloysius profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.